PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.\', \'Division of Hematology/Oncology, University of Arizona College of Medicine, Tucson, Arizona, USA.\', \'Division of Transplant Surgery, Vanderbilt University, Nashville, Tennessee, USA.\', \'Division of Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Division of Hematology/Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/tid.13792
?:doi
?:hasPublicationType
?:journal
  • Transplant infectious disease : an official journal of the Transplantation Society
is ?:pmid of
?:pmid
?:pmid
  • 35030267
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all